← Back to Search

Implementation Support Strategies for Disruptive Behaviors (SKIPforPA Trial)

N/A

Recruiting

Led By David J Kolko, PhD

Research Sponsored by University of Pittsburgh

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

PM Participants: Employed at one of the up to twenty-four (24) pediatric primary care practices identified by the PA Medical Home Program at the PA AAP or by the University of Pittsburgh research team. Identified by the practice as the Practice Manager or equivalent position. Are responsible for day-to-day practice operations, such as personnel management, billing, and compliance with regulations, in the pediatric practice.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months after caregiver baseline

Awards & highlights

SKIPforPA Trial Summary

This trial will test whether team- and practice leadership-level implementation strategies can help increase the use and uptake of a chronic care model-based intervention in diverse pediatric primary care offices.

Who is the study for?

This trial is for caregivers with a child aged 5-12 showing behavior problems, and staff at selected pediatric practices in PA. Staff roles include primary care providers, care managers, medical directors/senior leaders, and practice managers.Check my eligibility

What is being tested?

The study tests if extra support strategies for teams and leadership can improve the use of DOCC—an effective treatment program for childhood behavior issues and ADHD—in various pediatric offices.See study design

What are the potential side effects?

Since this trial focuses on implementation strategies rather than medications or direct treatments, it does not have typical side effects like those associated with drugs or medical procedures.

SKIPforPA Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a Practice Manager at a pediatric care practice selected for the study.

SKIPforPA Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ throughout services after each contact, up to 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~throughout services after each contact, up to 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and throughout services after each contact, up to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Care management competencies and functions

Change from baseline in Pediatric Health Quality at 12 months

Change from baseline in Pediatric Health Quality at 3 months

+14 more

SKIPforPA Trial Design

4Treatment groups

Experimental Treatment

Active Control

Group I: DOCC with TEAM implementationExperimental Treatment2 Interventions

Practices in this arm will receive DOCC training and materials and one type of implementation support after the training: coaching/consultation for the provider care team (TEAM).

Group II: DOCC with TEAM + LEAD implementationExperimental Treatment3 Interventions

Practices in this arm will receive DOCC training and materials and both types of implementation support after the training: coaching/consultation for the provider care team (TEAM) and facilitation for practice leadership (LEAD).

Group III: DOCC with LEAD implementationExperimental Treatment2 Interventions

Practices in this arm will receive DOCC training and materials and only one type of implementation support after the training: facilitation for practice leadership (LEAD).

Group IV: DOCC with standard implementation (No TEAM or LEAD)Active Control1 Intervention

Practices in this arm will receive DOCC materials/training and technical support, but will not receive care team coaching/consultation (TEAM) or practice leadership facilitation (LEAD) after the training phase.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

NYU Langone HealthOTHER

1,368 Previous Clinical Trials

839,276 Total Patients Enrolled

12 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)

678 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)

University of MichiganOTHER

1,797 Previous Clinical Trials

6,377,608 Total Patients Enrolled

7 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)

1,245 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)

Pennsylvania Chapter American Academy of PediatricsUNKNOWN

Media Library

DOCC: Evidence-based treatment for disruptive behavior and ADHD Clinical Trial Eligibility Overview. Trial Name: NCT04946253 — N/A

Attention Deficit Hyperactivity Disorder (ADHD) Research Study Groups: DOCC with LEAD implementation, DOCC with TEAM + LEAD implementation, DOCC with standard implementation (No TEAM or LEAD), DOCC with TEAM implementation

Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial 2023: DOCC: Evidence-based treatment for disruptive behavior and ADHD Highlights & Side Effects. Trial Name: NCT04946253 — N/A

DOCC: Evidence-based treatment for disruptive behavior and ADHD 2023 Treatment Timeline for Medical Study. Trial Name: NCT04946253 — N/A

Attention Deficit Hyperactivity Disorder (ADHD) Patient Testimony for trial: Trial Name: NCT04946253 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available slots in this clinical trial for participants?

"Affirmative. The information provided on clinicaltrials.gov indicates that the study is actively enrolling participants, having been first posted in late November 2021 and updated most recently at the start of November 2022. 600 individuals need to be recruited from two distinct trial sites."

Answered by AI

How many participants are being recruited for the clinical trial?

"Correct. As per the data hosted on clinicaltrials.gov, this medical trial is proactively recruiting participants and has been since its inception on November 29th 2021. The study aims to enlist 600 patients between 2 sites by 11/7/2022."

Answered by AI